Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: A population-based study

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3294-3304

  Szabo, Shelagh M ^a   Levy, Adrian R ^a,b   Rao, Sumati R ^c   Kirbach, Stephanie E ^c   Lacaille, Diane ^d   Cifaldi, Mary ^c   Maksymowych, Walter P ^e  

^a ICON PLC   (United Kingdom)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; AORTA VALVE DISEASE; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VALVULAR HEART DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUEBEC; RETROSPECTIVE STUDIES; RISK; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 80155130095     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30581     Document Type: Article

References (49)

1. Kinsella TD, Johnson LG, Ian R,. Cardiovascular manifestations of ankylosing spondylitis. Can Med Assoc J 1974; 111: 1309-11.
2. Sukenik S, Pras A, Buskila D, Katz A, Snir Y, Horowitz J,. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol 1987; 6: 588-92.
3. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV,. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-72. (Pubitemid 44749774)
4. Peters MJ, Visman I, Nielen MM, Van Dillen N, Verheij RA, van der Horst-Bruinsma IE, et al. Ankylosing spondylitis: a risk factor for myocardial infarction? Ann Rheum Dis 2010; 69: 579-81.
5. Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 2008; 196: 306-12.
6. Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S,. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol 2002; 21: 129-34. (Pubitemid 34649594)
7. Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ,. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 1992; 51: 227-32.
8. Dik VK, Peters MJ, Dijkmans PA, van der Weijden MA, De Vries MK, Dijkmans BA, et al. The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 2010; 39: 38-41.
9. O'Neill TW, Bresnihan B,. The heart in ankylosing spondylitis. Ann Rheum Dis 1992; 51: 705-6.
10. Bergfeldt L, Vallin H, Edhag O,. Complete heart block in HLA B27 associated disease: electrophysiological and clinical characteristics. Br Heart J 1984; 51: 184-8. (Pubitemid 14164673)
11. Sherer Y, Shoenfeld Y,. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006; 2: 99-106. (Pubitemid 43239209)
12. Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R,. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 2005; 109: 171-6. (Pubitemid 41117300)
13. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT,. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34: 585-92. (Pubitemid 39643120)
14. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
15. Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK,. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 2005; 32: 516-23. (Pubitemid 40381425)
16. Bergfeldt L,. HLA-B27-associated cardiac disease. Ann Intern Med 1997; 127: 621-9.
17. Boyer GS, Templin DW, Bowler A, Lawrence RC, Everett DF, Heyse SP, et al. A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study: has the classic case misled us? Arch Intern Med 1997; 157: 2111-7. (Pubitemid 27431280)
18. Kapur V, Basu K,. Drug coverage in Canada: who is at risk? Health Policy 2005; 71: 181-93. (Pubitemid 39647629)
19. Regie de l'assurance maladie du Quebec (RAMQ): statistiques annuelles 1993. Gouvernement du Québec; 1994.
20. Berard A, Lacasse A,. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. Can J Clin Pharmacol 2009; 16: e360-9.
21. Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA,. Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 1999; 15: 1277-82. (Pubitemid 30006767)
22. Regie de l'assurance maladie du Quebec (RAMQ): 2010. URL:.
23. Statistics Canada. 2006 population census for Canada, provinces, and territories. Statistics Canada. CANSIM. URL:.
24. Singh JA, Holmgren AR, Krug H, Noorbaloochi S,. Accuracy of the diagnoses of spondylarthritides in Veterans Affairs medical center databases. Arthritis Rheum 2007; 57: 648-55. (Pubitemid 46764056)
25. Thirumurthi S, Chowdhury R, Richardson P, Abraham NS,. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci 2010; 55: 2592-8.
26. Szklo M, Nieto FJ,. Epidemiology: beyond the basics. Sudbury (MA): Jones & Bartlett; 2004.
27. Frome EL, Checkoway H,. Epidemiologic programs for computers and calculators: use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 1985; 121: 309-23. (Pubitemid 15158542)
28. Maksymowych WP,. Update on the treatment of ankylosing spondylitis. Ther Clin Risk Manag 2007; 3: 1125-33.
29. Brunner F, Kunz A, Weber U, Kissling R,. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol 2006; 25: 24-9.
30. Nagyhegyi G, Nadas I, Banyai F, Luzsa G, Geher P, Molnar J, et al. Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol 1988; 6: 17-26.
31. Bremander A, Peterrson IF, Bergman S, Englund M,. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011; 63: 550-6.
32. Weisman MH, Reveille JD, van der Heijde D,. Ankylosing spondylitis and the spondyloarthopathies: a companion to rheumatology. Philadelphia: Mosby Elsevier; 2006.
33. So L, Evans D, Quan H,. ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 2006; 6: 161.
34. Kokotailo RA, Hill MD,. Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10. Stroke 2005; 36: 1776-81. (Pubitemid 41098778)
35. Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF,. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005; 43: 480-5. (Pubitemid 40694609)
36. Zaher C, Goldberg GA, Kadlubek P,. Estimating angina prevalence in a managed care population. Am J Manag Care 2004; 10; S339-46.
37. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statisticsâ2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
38. Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G,. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006; 13: 581-98. (Pubitemid 43873630)
39. Dincer U, Cakar E, Kiralp MZ, Dursun H,. Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 2008; 27: 457-62. (Pubitemid 351404300)
40. Suissa S,. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008; 167: 492-9.
41. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8. (Pubitemid 14134775)
42. Eder L, Sadek M, Donald-Blumer H, Gladman DD,. Aortitis and spondyloarthritisâan unusual presentation: case report and review of the literature. Semin Arthritis Rheum 2010; 39: 510-4.
43. Mader R,. Atypical clinical presentation of ankylosing spondylitis. Semin Arthritis Rheum 1999; 29: 191-6. (Pubitemid 30013283)
44. Joven J, Rubies-Prat J, Ras MR, de la Fiquera M, Lience E, Masdeu S,. High density lipoprotein cholesterol subfractions and apoprotein A-I in patients with rheumatoid arthritis and ankylosing spondylitis [letter]. Arthritis Rheum 1984; 27: 1199-200.
45. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ, et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005; 7: R984-91.
46. Zochling J, Braun J,. Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008; 26: S80-4.
47. Rothman KJ,. Causes. Am J Epidemiol 1976; 104: 587-92.
48. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-7. (Pubitemid 36314415)
49. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT,. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009; 68: 1131-5.